Artificial intelligence executives often disagree on regulation, open-weight models, and the pace at which new systems should be released. But one issue continues to draw broad agreement across the industry: the risk that advanced AI could someday be misused in biological research.
The discussion has become increasingly prominent as governments, technology companies and national security officials examine the capabilities of frontier AI models and the safeguards surrounding them. It has also gained attention amid growing geopolitical tensions and heightened concerns over biological preparedness in the years following the COVID-19 pandemic.
